309 related articles for article (PubMed ID: 27429020)
1. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
[TBL] [Abstract][Full Text] [Related]
2. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.
Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ
Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560
[TBL] [Abstract][Full Text] [Related]
3. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.
Schmitz R; Adam MA; Blazer DG
World J Surg Oncol; 2019 Nov; 17(1):180. PubMed ID: 31684956
[TBL] [Abstract][Full Text] [Related]
4. Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy.
Hue JJ; Sugumar K; Markt SC; Hardacre JM; Ammori JB; Rothermel LD; Winter JM; Ocuin LM
Surgery; 2021 Jul; 170(1):207-214. PubMed ID: 33454134
[TBL] [Abstract][Full Text] [Related]
5. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.
Lopez Ramos C; Brandel MG; Steinberg JA; Wali AR; Rennert RC; Santiago-Dieppa DR; Sarkar RR; Pannell JS; Murphy JD; Khalessi AA
J Neurooncol; 2019 Jan; 141(1):159-166. PubMed ID: 30460629
[TBL] [Abstract][Full Text] [Related]
6. Accessing surgical care for pancreaticoduodenectomy: Patient variation in travel distance and choice to bypass hospitals to reach higher volume centers.
Diaz A; Burns S; Paredes AZ; Pawlik TM
J Surg Oncol; 2019 Dec; 120(8):1318-1326. PubMed ID: 31701535
[TBL] [Abstract][Full Text] [Related]
7. Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense?
Kulshrestha S; Sweigert PJ; Tonelli C; Bunn C; Luchette FA; Abdelsattar ZM; Pawlik TM; Baker MS
J Surg Oncol; 2022 Mar; 125(3):414-424. PubMed ID: 34617590
[TBL] [Abstract][Full Text] [Related]
8. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
Speicher PJ; Englum BR; Ganapathi AM; Wang X; Hartwig MG; D'Amico TA; Berry MF
Ann Surg; 2017 Apr; 265(4):743-749. PubMed ID: 28266965
[TBL] [Abstract][Full Text] [Related]
9. Volume-outcome relationships in pancreatoduodenectomy for cancer.
van der Geest LG; van Rijssen LB; Molenaar IQ; de Hingh IH; Groot Koerkamp B; Busch OR; Lemmens VE; Besselink MG;
HPB (Oxford); 2016 Apr; 18(4):317-24. PubMed ID: 27037200
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy.
Kantor O; Talamonti MS; Sharpe S; Lutfi W; Winchester DJ; Roggin KK; Bentrem DJ; Prinz RA; Baker MS
Am J Surg; 2017 Mar; 213(3):512-515. PubMed ID: 28049562
[TBL] [Abstract][Full Text] [Related]
11. Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis.
Kutlu OC; Lee JE; Katz MH; Tzeng CD; Wolff RA; Varadhachary GR; Vauthey JN; Fleming JB; Conrad C
Ann Surg; 2018 Mar; 267(3):552-560. PubMed ID: 28045744
[TBL] [Abstract][Full Text] [Related]
12. Impact of surgical experience on management and outcome of pancreatic surgery performed in high- and low-volume centers.
Stella M; Bissolati M; Gentile D; Arriciati A
Updates Surg; 2017 Sep; 69(3):351-358. PubMed ID: 28215039
[TBL] [Abstract][Full Text] [Related]
13. Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base.
Sharpe SM; Talamonti MS; Wang CE; Prinz RA; Roggin KK; Bentrem DJ; Winchester DJ; Marsh RD; Stocker SJ; Baker MS
J Am Coll Surg; 2015 Jul; 221(1):175-84. PubMed ID: 26095569
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
[TBL] [Abstract][Full Text] [Related]
15. Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield.
Warschkow R; Tsai C; Köhn N; Erdem S; Schmied B; Nussbaum DP; Gloor B; Müller SA; Blazer D; Worni M
Langenbecks Arch Surg; 2020 Feb; 405(1):43-54. PubMed ID: 32040705
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
[TBL] [Abstract][Full Text] [Related]
17. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.
Ravikumar R; Sabin C; Abu Hilal M; Bramhall S; White S; Wigmore S; Imber CJ; Fusai G;
J Am Coll Surg; 2014 Mar; 218(3):401-11. PubMed ID: 24484730
[TBL] [Abstract][Full Text] [Related]
18. Comparison of survival of stage I-III colon cancer by travel distance and hospital volume.
Turner MC; Jawitz O; Adam MA; Srinivasan E; Niedzwiecki D; Migaly J; Fisher DA; Mantyh CR
Tech Coloproctol; 2020 Jul; 24(7):703-710. PubMed ID: 32281019
[TBL] [Abstract][Full Text] [Related]
19. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
[TBL] [Abstract][Full Text] [Related]
20. Going the distance in acoustic neuroma resection: microsurgical outcomes at high-volume centers of excellence.
Brandel MG; Plonsker JH; Khan UA; Rennert RC; Friedman RA; Schwartz MS
J Neurooncol; 2023 May; 163(1):105-114. PubMed ID: 37084124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
